Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-17-065943
Filing Date
2017-12-15
Accepted
2017-12-15 16:32:39
Documents
2
Period of Report
2017-12-13

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 3781
2 POA DOCUMENT poa.txt EX-24.4_757241 3301
  Complete submission text file 0001209191-17-065943.txt   8454
Mailing Address C/O ARIAD PHARMACEUTICALS, INC. 26 LANDSDOWNE STREET CAMBRIDGE MA 02139
Business Address
Cantor Maria E (Reporting) CIK: 0001542768 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36294 | Film No.: 171259352

Mailing Address PAASHEUVELWEG 25A AMSTERDAM P7 1105 BP
Business Address PAASHEUVELWEG 25A AMSTERDAM P7 1105 BP 1-339-970-7000
uniQure N.V. (Issuer) CIK: 0001590560 (see all company filings)

EIN.: 000000000
SIC: 2834 Pharmaceutical Preparations